Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Yasmeen Ezzeldeen, Shady Swidan, Aliaa ElMeshad & Aya Sebak. (2021) Green Synthesized Honokiol Transfersomes Relieve the Immunosuppressive and Stem-Like Cell Characteristics of the Aggressive B16F10 Melanoma. International Journal of Nanomedicine 16, pages 5693-5712.
Read now
Read now
Weiling Leng, Juan Jiang, Bing Chen & Qinan Wu. (2021) Metformin and Malignant Tumors: Not Over the Hill. Diabetes, Metabolic Syndrome and Obesity 14, pages 3673-3689.
Read now
Read now
Maike Zimmermann, Aruni P. S. Arachchige-Don, Michaela S. Donaldson, Tommaso Patriarchi & Mary C. Horne. (2016) Cyclin G2 promotes cell cycle arrest in breast cancer cells responding to fulvestrant and metformin and correlates with patient survival. Cell Cycle 15:23, pages 3278-3295.
Read now
Read now
Articles from other publishers (46)
XuLing Ji, Xiaoxia Huang, Chao Li, Ningning Guan, Tingting Pan, Jing Dong & Lin Li. (2023) Effect of tumor-associated macrophages on the pyroptosis of breast cancer tumor cells. Cell Communication and Signaling 21:1.
Crossref
Crossref
Mahmoud Al-Azab, Elina Idiiatullina, Mohammed Safi & Kamal Hezam. (2023) Enhancers of mesenchymal stem cell stemness and therapeutic potency. Biomedicine & Pharmacotherapy 162, pages 114356.
Crossref
Crossref
Kosuke Ota, Satoshi Sakai, Tatsuya Ohhata, Takahito Suzuki, Chiharu Uchida, Hiroyuki Niida & Masatoshi Kitagawa. (2023)
APOBEC3B expression is promoted by
lincNMR
collaborating with TGF-β–Smad pathway
. Carcinogenesis 44:1, pages 1-14.
Crossref
Crossref
Jianhong Liu, Ming Zhang, Dan Deng & Xiao Zhu. (2023) The function, mechanisms, and clinical applications of metformin: potential drug, unlimited potentials. Archives of Pharmacal Research 46:5, pages 389-407.
Crossref
Crossref
Miran Rada, Lucyna Krzywon, Stephanie Petrillo, Anthoula Lazaris & Peter Metrakos. (2023) A Retrospective Study on the Role of Metformin in Colorectal Cancer Liver Metastases. Biomedicines 11:3, pages 731.
Crossref
Crossref
Kuniko HunterJaclyn A. LarsenHarold D. LoveRachel C. EvansShuvo RoyRoy ZentRaymond C. HarrisMatthew H. WilsonWilliam H. Fissell. (2023) Inhibition of Transforming Growth Factor-β Improves Primary Renal Tubule Cell Differentiation in Long-Term Culture. Tissue Engineering Part A 29:3-4, pages 102-111.
Crossref
Crossref
Ruoning Yang, Yueyi Li, Hang Wang, Taolin Qin, Xiaomeng Yin & Xuelei Ma. (2022) Therapeutic progress and challenges for triple negative breast cancer: targeted therapy and immunotherapy. Molecular Biomedicine 3:1.
Crossref
Crossref
Kojo Agyemang, Allan M. Johansen, Grayson W. Barker, Michael J. Pennison, Kimberly Sheffield, Hugo Jimenez, Carl Blackman, Sambad Sharma, Patrick A. Fordjour, Ravi Singh, Katherine L. Cook, Hui-Kuan Lin, Wei Zhang, Hui-Wen Lo, Kounosuke Watabe, Peiqing Sun, Carl D. Langefeld & Boris Pasche. (2022) TGFBR1*6A as a modifier of breast cancer risk and progression: advances and future prospects. npj Breast Cancer 8:1.
Crossref
Crossref
K. O. Kuznetsov, E. R. Safina, D. V. Gaimakova, Ya. S. Frolova, I. Yu. Oganesyan, A. G. Sadertdinova, K. A. Nazmieva, A. H. Islamgulov, A. R. Karimova, A. M. Galimova & E. V. Rizvanova. (2022) Metformin and malignant neoplasms: a possible mechanism of antitumor action and prospects for use in practice. Problems of Endocrinology 68:5, pages 45-55.
Crossref
Crossref
Busra Buyuk, Sha Jin & Kaiming Ye. (2021) Epithelial-to-Mesenchymal Transition Signaling Pathways Responsible for Breast Cancer Metastasis. Cellular and Molecular Bioengineering 15:1, pages 1-13.
Crossref
Crossref
Nicole Ramos-Solis & Elizabeth S. Yeh. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
35
48
.
Andrew Sulaiman, Sarah McGarry, Sai Charan Chilumula, Rohith Kandunuri & Vishak Vinod. (2021) Clinically Translatable Approaches of Inhibiting TGF-β to Target Cancer Stem Cells in TNBC. Biomedicines 9:10, pages 1386.
Crossref
Crossref
Madhavi Gangapuram, Elizabeth A. Mazzio, Kinfe K. Redda & Karam F. A. Soliman. (2021) Transcriptome Profile Analysis of Triple-Negative Breast Cancer Cells in Response to a Novel Cytostatic Tetrahydroisoquinoline Compared to Paclitaxel. International Journal of Molecular Sciences 22:14, pages 7694.
Crossref
Crossref
Kah Keng Wong. (2021) DNMT1: A key drug target in triple-negative breast cancer. Seminars in Cancer Biology 72, pages 198-213.
Crossref
Crossref
Jeonghyeon Moon, Seon-yeong Lee, Jeong Won Choi, A Ram Lee, Jin Hee Yoo, Su-Jin Moon, Sung-Hwan Park & Mi-La Cho. (2021) Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts. Journal of Translational Medicine 19:1.
Crossref
Crossref
Mohammad Jalalirad, Tufia C. Haddad, Jeffrey L. Salisbury, Derek Radisky, Minzhi Zhang, Mark Schroeder, Ann Tuma, Eduard Leof, Jodi M. Carter, Amy C. Degnim, Judy C. Boughey, Jann Sarkaria, Jia Yu, Liewei Wang, Minetta C. Liu, Luca Zammataro, Lorenzo Malatino, Evanthia Galanis, James N. Ingle, Matthew P. Goetz & Antonino B. D’Assoro. (2021) Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance. Oncogene 40:14, pages 2509-2523.
Crossref
Crossref
Bikash Chandra Jena, Chandan Kanta Das, Indranil Banerjee, Subhayan Das, Deblina Bharadwaj, Ranabir Majumder & Mahitosh Mandal. (2021) Paracrine TGF-β1 from breast cancer contributes to chemoresistance in cancer associated fibroblasts via upregulation of the p44/42 MAPK signaling pathway. Biochemical Pharmacology 186, pages 114474.
Crossref
Crossref
Mahsa Golshan, Saeedeh Khaleghi, Sayed Mohammad Shafiee, Shiva Valaee, Zahra Ghanei, Abbas Jamshidizad, Mojtaba Dashtizad & Mehdi Shamsara. (2020) Metformin modulates oncogenic expression of HOTAIR gene via promoter methylation and reverses epithelial–mesenchymal transition in MDA‐MB‐231 cells. Journal of Cellular Biochemistry 122:3-4, pages 385-393.
Crossref
Crossref
Marketa Koleckova, Jiri Ehrmann, Jan Bouchal, Maria Janikova, Aneta Brisudova, Josef Srovnal, Katerina Staffova, Marek Svoboda, Ondrej Slaby, Lenka Radova, Katherine Vomackova, Bohuslav Melichar, Lucia Veverkova & Zdenek Kolar. (2021) Epithelial to mesenchymal transition and microRNA expression are associated with spindle and apocrine cell morphology in triple-negative breast cancer. Scientific Reports 11:1.
Crossref
Crossref
Fayola Levine & Olorunseun O. Ogunwobi. (2021) Targeting PVT1 Exon 9 Re-Expresses Claudin 4 Protein and Inhibits Migration by Claudin—Low Triple Negative Breast Cancer Cells. Cancers 13:5, pages 1046.
Crossref
Crossref
Emmanuel Rosas, Justin T Roberts, Kathleen I O’Neill, Jessica L Christenson, Michelle M Williams, Toru Hanamura, Nicole S Spoelstra, Jeffery M Vahrenkamp, Jason Gertz & Jennifer K Richer. (2021) A Positive Feedback Loop Between TGFβ and Androgen Receptor Supports Triple-negative Breast Cancer Anoikis Resistance. Endocrinology 162:2.
Crossref
Crossref
Alan Carrasco-Carballo, María Guadalupe Hernández-Linares, Maura Cárdenas-García & Jesús Sandoval-Ramírez. (2021) Synthesis and biological in vitro evaluation of the effect of hydroxyimino steroidal derivatives on breast cancer cells. Steroids 166, pages 108787.
Crossref
Crossref
Jiahong Chen, Yaqiang Huang, Zhenfeng Tang, Maozhang Li, Xiaohui Ling, Jinxian Liao, Xiaobo Zhou, Shumin Fang, Haibo Zhao, Weide Zhong & Xia Yuan. (2021) Genome-Scale CRISPR-Cas9 Transcriptional Activation Screening in Metformin Resistance Related Gene of Prostate Cancer. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Emmanuel Rosas & Jennifer Richer. 2021. Anoikis. Anoikis
173
192
.
Samson Mathews Samuel, Elizabeth Varghese, Lenka Koklesová, Alena Líšková, Peter Kubatka & Dietrich Büsselberg. (2020) Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells. Cancers 12:9, pages 2482.
Crossref
Crossref
Qianqian Zheng, Jian Gao, Ping Yin, Wei Wang, Biao Wang, Yan Li & Chenghai Zhao. (2020) CD155 contributes to the mesenchymal phenotype of triple‐negative breast cancer. Cancer Science 111:2, pages 383-394.
Crossref
Crossref
Max Kosok, Asfa Alli-Shaik, Boon Huat Bay & Jayantha Gunaratne. (2020) Comprehensive Proteomic Characterization Reveals Subclass-Specific Molecular Aberrations within Triple-negative Breast Cancer. iScience 23:2, pages 100868.
Crossref
Crossref
Reema S. Wahdan-Alaswad & Ann D. Thor. 2020. Metformin [Working Title]. Metformin [Working Title].
Xia Liao, Yang Bu, Shanshan Jiang, Fan Chang, Fengan Jia, Xuelian Xiao, Ge Song, Mei Zhang, Pengbo Ning & Qingan Jia. (2019) CCN2–MAPK–Id-1 loop feedback amplification is involved in maintaining stemness in oxaliplatin-resistant hepatocellular carcinoma. Hepatology International 13:4, pages 440-453.
Crossref
Crossref
Forouzan Amerizadeh, Afsane Bahrami, Majid Khazaei, AmirReza Hesari, Majid Rezayi, Sahar Talebian, Mona Maftouh, Mehrdad Moetamani‐Ahmadi, Sima Seifi, Soodabeh Shahidsales, Mona Joudi‐Mashhad, Gordon A. Ferns, Faezeh Ghasemi & Amir Avan. (2019) Current status and future prospects of transforming growth factor‐β as a potential prognostic and therapeutic target in the treatment of breast cancer. Journal of Cellular Biochemistry 120:5, pages 6962-6971.
Crossref
Crossref
Federica Barbieri, Ivan Verduci, Valentina Carlini, Gianluigi Zona, Aldo Pagano, Michele Mazzanti & Tullio Florio. (2019) Repurposed Biguanide Drugs in Glioblastoma Exert Antiproliferative Effects via the Inhibition of Intracellular Chloride Channel 1 Activity. Frontiers in Oncology 9.
Crossref
Crossref
Kancheng He, Huating Hu, Senlin Ye, Haohui Wang, Rongrong Cui & Lu Yi. (2019) The effect of metformin therapy on incidence and prognosis in prostate cancer: A systematic review and meta-analysis. Scientific Reports 9:1.
Crossref
Crossref
Maryam Nakhjavani, Jennifer E Hardingham, Helen M Palethorpe, Tim J Price & Amanda R Townsend. (2019) Druggable Molecular Targets for the Treatment of Triple Negative Breast Cancer. Journal of Breast Cancer 22:3, pages 341.
Crossref
Crossref
Olivera Bozickovic, Linn Skartveit, Agnete S.T. Engelsen, Thomas Helland, Kristin Jonsdottir, Marianne Hauglid Flågeng, Ingvild S. Fenne, Emiel Janssen, James B. Lorens, Lise Bjørkhaug, Jørn V. Sagen & Gunnar Mellgren. (2019) A novel SRC-2-dependent regulation of epithelial-mesenchymal transition in breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology 185, pages 57-70.
Crossref
Crossref
Jamie L. King, Baotong Zhang, Yixiang Li, Kathy P. Li, Jianping J. Ni, Harold I. Saavedra & Jin-Tang Dong. (2018) TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer. Oncogenesis 7:9.
Crossref
Crossref
Yaodu Wang, Zhiyang Wu & Likuan Hu. (2018) The regulatory effects of metformin on the [SNAIL/miR-34]:[ZEB/miR-200] system in the epithelial-mesenchymal transition(EMT) for colorectal cancer(CRC). European Journal of Pharmacology 834, pages 45-53.
Crossref
Crossref
Nan Wu, Jinghua Zhang, Jing Zhao, Kun Mu, Jun Zhang, Zhao Jin, Jinpu Yu & Juntian Liu. (2018) Precision medicine based on tumorigenic signaling pathways for triple‑negative breast cancer (Review). Oncology Letters.
Crossref
Crossref
Paola Mantuano, Francesca Sanarica, Elena Conte, Maria Grazia Morgese, Roberta Francesca Capogrosso, Anna Cozzoli, Adriano Fonzino, Angelo Quaranta, Jean-Francois Rolland, Michela De Bellis, Giulia Maria Camerino, Luigia Trabace & Annamaria De Luca. (2018) Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy. Biochemical Pharmacology 154, pages 89-103.
Crossref
Crossref
Ke Li, Ting-ting Zhang, Feng Wang, Bing Cui, Chen-xi Zhao, Jiao-jiao Yu, Xiao-xi Lv, Xiao-wei Zhang, Zhao-na Yang, Bo Huang, Xia Li, Fang Hua & Zhuo-wei Hu. (2018) Metformin suppresses melanoma progression by inhibiting KAT5-mediated SMAD3 acetylation, transcriptional activity and TRIB3 expression. Oncogene 37:22, pages 2967-2981.
Crossref
Crossref
Nipun Saini & Xiaohe Yang. (2018) Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells. Acta Biochimica et Biophysica Sinica 50:2, pages 133-143.
Crossref
Crossref
Malgorzata Tyszka-Czochara, Malgorzata Lasota & Marcin Majka. (2018) Caffeic Acid and Metformin Inhibit Invasive Phenotype Induced by TGF-β1 in C-4I and HTB-35/SiHa Human Cervical Squamous Carcinoma Cells by Acting on Different Molecular Targets. International Journal of Molecular Sciences 19:1, pages 266.
Crossref
Crossref
Junqing Chen, Zhanhong Chen, Jian Huang, Feng Chen, Weiwu Ye, Guojun Ding & Xiaojia Wang. (2017) Bioinformatics identification of dysregulated microRNAs in triple negative breast cancer based on microRNA expression profiling. Oncology Letters.
Crossref
Crossref
Richard E. Kast, Nicolas Skuli, Georg Karpel-Massler, Guido Frosina, Timothy Ryken & Marc-Eric Halatsch. (2017) Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen. Oncotarget 8:37, pages 60727-60749.
Crossref
Crossref
Arjun P. Athreya, Krishna R. Kalari, Junmei Cairns, Alan J. Gaglio, Quin F. Wills, Nifang Niu, Richard Weinshilboum, Ravishankar K. Iyer & Liewei Wang. (2017) Model-based unsupervised learning informs metformin-induced cell-migration inhibition through an AMPK-independent mechanism in breast cancer. Oncotarget 8:16, pages 27199-27215.
Crossref
Crossref
Peiguo Shi, Wenjing Liu, Tala, Haixia Wang, Fubing Li, Hailin Zhang, Yingying Wu, Yanjie Kong, Zhongmei Zhou, Chunyan Wang, Wenlin Chen, Rong Liu & Ceshi Chen. (2017) Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation. Cell Discovery 3:1.
Crossref
Crossref
L. Allyson Checkley, Michael C. Rudolph, Elizabeth A. Wellberg, Erin D. Giles, Reema S. Wahdan-Alaswad, Julie A. Houck, Susan M. Edgerton, Ann D. Thor, Pepper Schedin, Steven M. Anderson & Paul S. MacLean. (2017)
Metformin Accumulation Correlates with Organic Cation Transporter 2 Protein Expression and Predicts Mammary Tumor Regression
In Vivo
. Cancer Prevention Research 10:3, pages 198-207.
Crossref
Crossref